ACS
CRL icon

Archford Capital Strategies’s Charles River Laboratories CRL Stock Holding History

Archford Capital Strategies’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-48
Closed -$7K – 279
2019
Q2 		$7K Hold
48
– – ﹤0.01% 429
2019
Q1 		$7K Hold
48
– – ﹤0.01% 406
2018
Q4 		$5K Hold
48
– – ﹤0.01% 401
2018
Q3 		$6K Hold
48
– – ﹤0.01% 430
2018
Q2 		$5K Hold
48
– – ﹤0.01% 464
2018
Q1 		$5K Buy
+48
New +$5.17K ﹤0.01% 381
2017
Q2 		– Sell
-48
Closed -$4K – 283
2017
Q1 		$4K Buy
+48
New +$4.08K ﹤0.01% 490

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return